Inflammatix, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Inflammatix, Inc. - overview
Established
2016
Location
Sunnyvale, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2016 by co-founders Timothy Sweeney, Ph. D. (CEO), Purvesh Khatri, Ph. D.
, and Jonathan Romanowsky, Inflammatix, Inc. operates as a provider of immune system-based diagnostic tests to assist healthcare professionals in determining the presence and severity of infections or sepsis in patients requiring emergency care. In September 2024, Inflammatix, Inc. raised USD 57 million in Series E funding co-led by Khosla Ventures and Think.
Health Ventures, with participation from OSF Ventures, D1 Capital Partners, Northpond Ventures, Raw Ventures, Vesalius Biocapital, and Iberis Capital. The company provides a wide range of diagnostic solutions, such as the TriVerity Acute Infection and Sepsis Test, which helps physicians distinguish between bacterial and viral infections and evaluate the need for ICU-level interventions. Further, the firm also provides advanced bioinformatics services leveraging machine learning and artificial intelligence for improved clinical decision-making. Additionally, the company also develops products such as the Myrna device, focusing on improving clinical decision-making through advanced immune response analysis.
The company plans to use its proceeds from September 2024 funding to facilitate early commercialization of its flagship product called TriVerity and regulatory filing.
Current Investors
Think.Health Ventures, Northpond Ventures, Khosla Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy, Diagnostic Equipment
Website
www.inflammatix.com/
Verticals
Manufacturing
Company Stage
Series E
Total Amount Raised
Subscriber access only
Inflammatix, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Group President, Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.